Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

NA Proactive news snapshot: United Lithium, AMPD Ventures, Valeo Pharma, CULT Food Science, Canada Silver Cobalt Works, Nickel North Exploration, Revive Therapeutics...

Published 2022-09-14, 10:00 a/m
Updated 2022-09-14, 10:15 a/m
© Reuters.  NA Proactive news snapshot: United Lithium, AMPD Ventures, Valeo Pharma, CULT Food Science, Canada Silver Cobalt Works, Nickel North Exploration, Revive Therapeutics...

United Lithium Corp (CSE:ULTH) has announced that drilling has commenced at the Kietyonmaki lithium project in Finland, with a first stage 10-hole drill program planned, with holes averaging 100 metres (m) in length. The aim of the drill program is to confirm current geological knowledge of the project as well as to provide enough geological data to model a mineralized body exceeding 500,000 tonnes with a grade of greater than 1% Li2O. If drill results are encouraging, a follow-up drill program of 400m can be commenced, the company added. The immediate surrounding of the Kietyonmaki Li-pegmatite will be further explored with a bedrock surface sampling program of 250 sample points.

AMPD Ventures Inc (CSE:AMPD, OTCQB:AMPDF) announced that Tanya Woods has been appointed to its board of directors, effective September 12, 2022. The company noted that Woods is a Canadian-American entrepreneur, technology lawyer, and policy leader working in the verticals of mainstream and digital media, telecommunications, AI and blockchain, and high-performance computing infrastructure. She is currently the CEO of Futurity Partners, a strategic consulting firm advising public and private sector organizations on exponential and innovative technologies, digital policy, and ESG matters. “I am delighted to be joining the experienced Board of AMPD Ventures as the company and its subsidiaries break ground in the metaverse,” said Woods in a statement, “the company's multi-faceted approach from enabling mobile high-performance computing infrastructure to supporting first-class metaverse and digital content creation is a unique and compelling innovation journey I look forward to talking with the team.”

Valeo (EPA:VLOF) Pharma Inc has posted record third-quarter revenue of $6.1 million compared to $5.7 million a year earlier, mainly on the back of continued commercial gains for its respiratory products Redesca, Enerzair and Atectura. The Canadian pharmaceutical company now expects fourth-quarter revenue to exceed $11.0 million as it reaps the benefits of its acquisitions as well as the organic growth of existing products, its CEO Steve Saviuk said. "Our quarterly revenues increased to record levels as a result of the continued commercial progress of our lead products,” Saviuk said in the results statement. “We are also very proud to have added three core commercial assets during this third quarter that will help more than double our annual revenues over the coming year."

CULT Food Science Corp (CSE:CULT, OTCQB:CULTF) has applauded the US Presidential Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for Sustainable, Safe, and Secure American Bioeconomy, which was published on September 12, 2022. The executive order details many responsibilities that must be upheld by the Government of the United States to improve biotechnology and create a safe, sustainable and secure food economy. “The Executive Order increases the momentum of much-needed change. We at CULT are comforted in seeing that the US Government has the same concerns about our food system and for change as us,” said Lejjy Gafour, CEO of CULT in a statement.

Canada Silver Cobalt Works Inc has said its 100%-owned Temiskaming Testing Labs (TTL) high-grade processing plant is fully operational and ready for processing the high-grade mineralized material from the Cobalt Camp into silver dore bars, as it was originally designed to do. "We have rebuilt the TTL facility, including upgrades to the secondary crushing circuit and installation of a new gravity plant. TTL is now ready to begin the processing of high-grade mineralized material and tailings from mining properties in the area, including tailings from the company's past-producing Beaver Mine and Castle Mine. This is another important step in building our capability as a fully integrated mining operation right through to the production of silver dore bars," said the company's CEO Frank J. Basa in a statement. The 20,000-square-foot TTL facility, which has zero discharge, is located in the Town of Cobalt, Ontario, in the centre of the historic Cobalt Mining Camp where 600 million ounces of silver and 30 million pounds of cobalt were produced during the 1900s. The facility was originally established in its current location by the Ontario government in 1941 as a public service facility offering laboratory services, high-grade ore processing and a bullion furnace to nearby mining operations.

Nickel North Exploration Corp (TSX-V:NNX) has said that on September 10, 2022, it completed phase one of the 2022 field works program at its Hawk Ridge Nickel-Copper-Cobalt-PGE Project. The company said its team conducted a project scale soil sampling, ground prospecting and rock sampling targeted on the 50 kilometre (km) long structure system at the Hawk Ridge Project. "We are pleased to have completed the 2022 phase 1 fieldwork which allowed us to identify and expand four high-grade Ni-Cu massive sulfide mineralized outcrops, these data, combined with surface mapping and sampling data will allow our team to better understand and model the distribution of and structural controls on the high-grade mineralization and to better interpret the significance of the high-grade 'Raglan type potato' zones,” Dr Tony Guo, CEO and president of Nickel North said in a statement.

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) said it has filed an amended protocol to the US Food & Drug Administration (FDA) for the company's Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine, an oral drug with anti-inflammatory and antiviral properties, for the treatment of patients with mild to moderate coronavirus (COVID-19). The company said the revised protocol addresses a new primary efficacy endpoint, specifically, the time to recovery from COVID-19 via the polymerase chain reaction (PCR) test and secondary endpoints, including evaluating time to clinical improvement, comparing the frequency of hospitalization or death, and disease course in patients with mild-moderate COVID-19 receiving Bucillamine therapy with those receiving placebo. “These proposed endpoints address the shift in COVID-19 clinical outcomes observed over the course of the pandemic, and, therefore, may have more meaningful study endpoints for the FDA to consider for regulatory approval,” it added.

Kainantu Resources Ltd (TSX-V:KRL) has told investors that three high-priority targets have been identified at the Ontenu area of its KRL South project in Papua New Guinea (PNG). Historic fieldwork in the area along with an airborne geophysical survey by the company in the first half of 2022 have shown it to host several highly prospective copper-gold targets, the company noted. The explorer said it was now engaging with the local community in a bid to support fieldwork at Ontenu in the second half of this year ahead of a potential drill program.

Copper Fox Metals Inc (TSX-V:CUU, OTCQX:CPFXF), through its wholly-owned subsidiary Northern Fox Copper Inc, said it has suspended plans to complete the proposed 2,500-metre (m) drilling program on its 100% owned Eaglehead polymetallic porphyry copper project. The project, approximately 50 kilometers (km) east of Dease Lake, British Columbia, covers a large portion of the Lower Jurassic age, Eaglehead stock. “The delay in receipt of the permit to conduct the drilling program has been an extremely frustrating exercise,” Elmer B. Stewart, president and CEO of Copper Fox said in a statement.

Renforth Resources Inc (CSE:RFR, OTCQB:RFHRF) revealed that fieldwork has started again at its wholly-owned 330 square kilometre (sq km) Surimeau battery metals district property in Quebec after the group received the required permit. The surface work is focused on the Lalonde structure, following up on the visual mineralization encountered during channel sampling earlier this summer, and Renforth will also be chipping, stripping and channel sampling target areas on the 20km long Victoria target, 3.5km south of Lalonde.

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) said it is finalizing its Phase 1 first-in-human clinical trial plan for its lead psychedelic drug candidate MSP-1014 for the treatment of major depressive disorder after receiving scientific advice from the UK Medicines and Healthcare products Regulatory Agency (MHRA). MSP-1014 is Mindset’s novel and patented, second-generation psilocybin-like drug candidate which it is developing in collaboration with specialized UK-based contract research organization Clerkenwell Health. According to the company, the MHRA has agreed with the company’s position and confirmed that, subject to CTA review, MSP-1014 will not require additional preclinical studies at this time.

Fabled Copper Corp has announced the completion of the 2022 field exploration programs on its Muskwa copper project, which is comprised of the Neil property, the Toro property and the Bronson property, in British Columbia. The junior mining exploration company said a total of 59 areas were prospected, mapped, and sampled property-wide, resulting in new claims added. “The 2022 exploration program was designed to focus on areas we studied last year, test structural theories with respect to new predictable of mineralized areas which has resulted in discoveries plus advance certain areas with respect to a potential 43-101 status at the end of 2023,” Fabled Copper CEO Peter Hawley said in a statement.

Bloom Health Partners Inc (CSE:BLMH, OTCQB:BLMHF) announced it has opened a new location in the Honolulu area of Hawaii. In a statement, the Vancouver-based health and technology company said that the new location will provide expanded laboratories for operational health services and diagnostic testing “to meet continued demand.” The new Honolulu location will be staffed by a local team.

TRACON Pharmaceuticals Inc (NASDAQ:TCON) announced that its undifferentiated pleomorphic sarcoma (UPS) drug envafolimab has been granted fast track designation by the US Food and Drug Administration. The designation covers the development of envafolimab for patients with locally advanced, unresectable or metastatic UPS and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy.

Murchison Minerals Ltd (TSX-V:MUR, OTCQB:MURMF, TSX-V:MUR.V) has announced results from the second diamond drillhole at the Barre de Fer (BDF) zone, as part of the 2022 summer exploration program at its 100%-owned Haut-Plateau de la Manicouagan (HPM) project in Quebec, showing substantial nickel, copper and cobalt mineralization. The BDF22-002 hole was drilled to a depth of 452 metres (m) and intersected two broad zones of nickel-copper-cobalt sulphide bearing mineralization totalling 175.15m of composite thickness. The results were analysed using portable x-ray fluorescence (pXRF), and showed a pXRF estimate of 1.39% nickel equivalent (or 4.14% copper equivalent), including 21m at 3.43% nickel equivalent (or 10.25% copper equivalent). The hole successfully confirmed mineralization down dip from DH-151-02, exceeding expectations. The hole also confirmed mineralization up dip of DH-151-05EX. Group, Inc said it has partnered with Velocity Global, a global work platform providing solutions for businesses and talent to work anyone, anywhere, anyhow. According to the company, Velocity Global’s Global Work Platform simplifies the employer and talent experience through its proprietary cloud-based talent management solution, which includes onboarding, managing, and paying talent worldwide. CEO Evan Sohn said the company was excited to enter this partnership with Velocity Global at this pivotal point in the job market.

Todos Medical Ltd announced that its CLIA/CAP-certified laboratory Provista Diagnostics has initiated a validation plan for PCR-based polio testing. The comprehensive medical diagnostics company said it intends to validate multiple polymerase chain reaction (PCR) assays for polio, including wastewater testing with ultra-high sensitivity. Low viral load diagnostic tests will be developed for early diagnosis and will be available for multiplexing with its other PCR panels. Todos noted that the global bioinformatics market was valued at US$13.2 billion in 2021 according to Precedence Research and is expected to grow at a compound annual growth rate of 16.3% to $45.6 billion by 2030.

Real Luck Group Ltd (TSX-V:LUCK, OTCQB:LUKEF) and its subsidiary companies, doing business as Luckbox, have announced that net gaming revenue (gross sales minus player winnings and promotions) climbed 144% and total player deposits jumped 197% during August 2022. The award-winning provider of licensed esports betting, sports betting and casino games said the early operational data and strong balance sheet supports management guidance for profitability exiting the first half of 2023.

KULR Technology Group Inc (NYSE:KULR) revealed that it has joined NAATBatt International, the premier trade association of developers, manufacturers, suppliers and users of battery technology in North America. As a platinum member, San Diego, California-based KULR will regularly participate in board meetings, allowing the company to connect with top policy makers in the space, discuss and develop cutting-edge technological advancements and remain at the forefront of battery technology. "KULR is at an inflection point as we position our thermal safety solutions platform to become further entrenched in the marketplace, ultimately providing us with an opportunity to optimize logistics as we continue investing in the localization of our production and supply chain to North America," KULR co-founder and CEO Michael Mo said in a statement. "Becoming a member of NAATBatt allows us to further that mission."

Perk Labs Inc, the company behind mobile commerce platform Perk Hero, told investors it continues to sign up new customers and aims to deliver more advanced functions to members later this year. In a wide-ranging corporate update, the tech group, which aims to help firms' transition to the digital economy, also said it was looking to reduce costs, expand in the US, and plans to announce a rebranding in October this year. Notably, Perk has changed its business model from a transaction-based B2C marketplace to a B2B software-as-a-service subscription-based model in the last year.

Globex Mining Enterprises Ltd is applauding new high-grade gold intersections from the Kewagama Gold Mine property, part of its wider royalty portfolio. Project owner Radisson Mining Resources (TSX-V:RDS) (Radisson Mining Resources (TSX-V:RDS)) recently announced numerous high grade gold intersections on Trends 3 and 4, including 17.11 grams per ton (g/t) gold (Au) over 2 metres (m) and 5.16 g/t Au over 1.70 m on Trend 3 and 8.69 g/t Au over 2.20 m including 29.50 g/t Au over 0.60 m along Trend 4. Globex Mining holds a 2% net smelter royalty on the Kewagama Gold Mine property.

Aftermath Silver (TSX-V:AAG) Ltd said the TSX Venture Exchange has consented to the extension in the expiry date of 7,921,199 warrants with a current expiry date of November 14, 2022, to a new expiry date of warrants November 14, 2023, at an unchanged exercise price of 25 cents. The warrants were issued under a private placement of 16.5 million shares with 8.25 million share purchase warrants attached, which was accepted for filing by the exchange effective November 18, 2019. Of the 8.25 million warrants originally issued, 328,801 have already been exercised by the holders.

Major Precious Metals Corp has announced that all matters presented for approval at its annual general and special shareholders' meeting held on September 12, 2022, were approved. A total of 101,569,242 common shares representing 38.56% of the company's issued and outstanding common shares were voted in person or represented by proxy at the meeting. In particular, resolutions approving the following matters were passed: The delisting of the company's shares from the NEO Exchange; the almost unanimous election of directors as submitted in the notice of meeting; the reappointment of Dale Matheson Carr-Hilton Labonte LLP as the company's independent auditor for the ensuing year and authorization for the directors to fix the auditor's remuneration; approval of the company's 20% rolling stock option plan; and approval pf the company's restricted share unit plan.

Co-Diagnostics Inc (NASDAQ:CODX) announced that the company will be sponsoring, presenting and hosting a booth at the Caribbean Public Health Agency 66th Annual Health Research Conference, being held virtually and in-person on September 15-17 in Jamaica. This year's theme for the conference is "COVID-19 and Digital Health: Transforming, Connecting, Informing Public Health." Co-Dx has been attending the CARPHA conference since 2016, and the company's booth and presentation will showcase Co-Diagnostics' infectious disease and vector control products to conference attendees, along with its upcoming Co-Dx PCR Home testing platform. The company's presentation will take place on Friday, September 16 at 10:15 am local time. Additional details, including registration information, can be found on the conference website

Read more on Proactive Investors CA


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.